All Resources

Alberta COVID-19 immunization policy

Description

The Alberta COVID-19 Immunization Policy (ACIP) sets out the requirements for the delivery of the COVID-19 Immunization Program.

Tags

COVID-19 vaccine : active surveillance and reporting of adverse events following immunization (AEFI)

Description

The monitoring of adverse events following immunization (AEFI) involving vaccines and biologicals administered in Alberta is an important evaluation component of the provincial immunization... More ≫

Description

The monitoring of adverse events following immunization (AEFI) involving vaccines and biologicals administered in Alberta is an important evaluation component of the provincial immunization program. This document has been developed specifically for COVID-19 vaccine AEFI active surveillance. Active AEFI surveillance for COVID-19 vaccine in Alberta involves a collaboration between Alberta Health, Alberta Health Services Provincial AEFI Team, and the Canadian National Vaccine Safety Network (CANVAS).

Tags

COVID-19 immunization : medical exemption policy

Description

Issued under the direction of the Chief Medical Officer of Health, this policy outlines the conditions that constitute a medical exemption from COVID-19 immunization.

Tags

Pneumococcal Polysaccharide 23-Valent immunization program

Description

As of January 1, 2019, pharmacists will be able to provide routine Pneumococcal Polysaccharide 23 –Valent vaccine (Pneumo-P 23) to eligible adults 65 years of age and older. This fact sheet... More ≫

Description

As of January 1, 2019, pharmacists will be able to provide routine Pneumococcal Polysaccharide 23 –Valent vaccine (Pneumo-P 23) to eligible adults 65 years of age and older. This fact sheet outlines the eligibility criteria for the vaccine and reporting requirements for pharmacists. Included is decision tree to assist pharmacists in determining client eligibility.

Tags